Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[Factors associated with changes in microalbuminuria during antihypertensive treatment].

Rovira E, Julve R, Pascual JM, Miralles A, Redon J.

Med Clin (Barc). 2000 May 20;114(19):721-5. Spanish.

PMID:
10919124
2.

Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.

Marin P, Julve R, Chaves FJ, Giner V, Pascual JM, Armengod ME, Redon J.

J Hum Hypertens. 2004 Jan;18(1):25-31.

PMID:
14688807
3.

Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.

Redon J, Rovira E, Miralles A, Julve R, Pascual JM.

Hypertension. 2002 Mar 1;39(3):794-8.

PMID:
11897766
4.

Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.

Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V.

J Diabetes Complications. 2008 Sep-Oct;22(5):303-8. doi: 10.1016/j.jdiacomp.2007.05.003. Epub 2008 Apr 16.

6.

Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.

Pascual JM, Rodilla E, Miralles A, Gonzalez C, Redon J.

J Hypertens. 2006 Nov;24(11):2277-84.

PMID:
17053551
7.

Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension.

Redon J, Chaves FJ, Liao Y, Pascual JM, Rovira E, Armengod ME, Cooper RS.

Hypertension. 2000 Jan;35(1 Pt 2):490-5.

PMID:
10642347
8.

Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.

Ruggenenti P, Perna A, Ganeva M, Ene-Iordache B, Remuzzi G; BENEDICT Study Group.

J Am Soc Nephrol. 2006 Dec;17(12):3472-81. Epub 2006 Nov 2.

9.

[Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].

Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.

Ann Cardiol Angeiol (Paris). 2012 Jun;61(3):218-23. doi: 10.1016/j.ancard.2012.05.002. Epub 2012 May 23. French.

PMID:
22695025
10.

Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.

Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE.

Diabetes Care. 1995 Nov;18(11):1434-41.

PMID:
8722066
11.
12.
13.

[Pulse wave velocity and urinary albumin excretion in hypertensive patients treated with perindopril].

Toblli JE, Bellido CA, Iavícoli OR, Costa M, Forcada P, Piñeiro DJ, Lerman J.

Medicina (B Aires). 2002;62(6):544-50. Spanish.

PMID:
12532688
14.

Microalbuminuria in essential hypertensives in treatment for hypertension.

Cruz HM, Cruzera AB, Cruz J.

Rev Hosp Clin Fac Med Sao Paulo. 1997 Sep-Oct;52(5):258-62.

PMID:
9595780
15.

Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension.

Redon J, Miralles A, Pascual JM, Baldó E, Robles RG, Carmena R.

J Hypertens. 1997 Jan;15(1):79-86.

PMID:
9050974
16.

Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.

Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.

Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. Epub 2005 Oct 20.

PMID:
16487914
17.

Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.

Alli C, Lombardo M, Zanni D, Agrati AM, Cassani M, Granata S.

Am J Hypertens. 1996 Nov;9(11):1068-76.

PMID:
8931831
18.

Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.

Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.

Am J Hypertens. 1995 Aug;8(8):808-14.

PMID:
7576397
19.

Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.

Galceran J, Plana J, Felip A, Pou G, Vila J, Sobrino J.

Expert Rev Cardiovasc Ther. 2010 Jun;8(6):751-7. doi: 10.1586/erc.10.48. Review.

PMID:
20528630

Supplemental Content

Support Center